Back to top

Deutsche Bank Keeps Their Hold Rating on GlaxoSmithKline (GSK)

Deutsche Bank analyst Emmanuel Papadakis reiterated a Hold rating on GlaxoSmithKline today and set a price target of p2,000.00. Papadakis covers th...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

GSK PLC Sponsored ADR (GSK)